CARI is a NIH and NSF funded biosensor company on a mission to help patients who are suffering from chronic conditions, such as opioid use disorders (OUDs), return to leading normal lives. 

Our Team

Patrik Schmidle

CO-FOUNDER & CEO

For the first part of his career Patrik worked in various start-ups, mid-sized, privately-held companies as well as large, publicly-traded companies, primarily in the B2B software and market research industries where client lists included many leading technology companies. He took on as many different roles as possible to learn about all aspects of business, always with the goal becoming an entrepreneur. After being part of six acquisitions as an employee, he was inspired to found CARI Therapeutics after watching a close family member’s struggle with opioids. Since then, he’s been leading a team of clinicians, bio-chemical and electrical engineers on a mission to build a company that will have a positive and lasting impact on the opioid crisis.

Mark V. Weckwerth, Ph.D.

CHIEF OPERATING OFFICER

Dr. Weckwerth is an experienced executive who has built and led multiple organizations optimized for the development, manufacture, and sale of FDA-regulated therapeutic and diagnostic medical devices.  He is the former CEO of Leaf Healthcare, Inc., a vanguard of healthcare internet-of-things (IoT), which in 2013, began marketing a patient monitoring system that features a wearable, wireless, disposable sensor.  He excels at bringing novel products from concept to commercialization, assembling expert teams, and developing business models and go-to-market strategies for both the home and professional markets.

Torsten Fiebig, Ph.D.

CHIEF SCIENCE OFFICER

Dr. Fiebig is a CalTech trained chemist and entrepreneur who straddles the line between academia and private industry. He has extensive expertise in analytical and biophysical chemistry, in addition to having founded several businesses. Dr. Fiebig received his Ph.D. in chemistry at the Max Planck Institute for Biophysical Chemistry, Germany.

Jon S. Wilensky, MD MBA FACS

BOARD CERTIFIED PLASTIC SURGEON
CHIEF MEDICAL OFFICER

Dr. Jon Wilensky is a Board Certified Plastic and Reconstructive Surgeon, whose practice is exclusively dedicated to implantable, injectable, and wearable biotechnology. He has served as a Surgical and Technical Consultant to multiple industry partners including diabetes pioneers GlySens and ViaCyte. He is also an experienced Founder and Bioentrepreneur, and holds an MBA from the Rady School of Management. He is on the active Medical Staffs of Scripps Health and Palomar Health, the latter a member of the Mayo Clinic Care Network. His passion is to radically solve the biggest problems in healthcare with disruptive, breakthrough technologies.

Carla Marienfeld, MD

CLINICAL ADVISOR

Carla Marienfeld, MD, DFAPA, FASAM is board-certified in psychiatry, addiction psychiatry, and addiction medicine, and she is a Clinical Professor at the University of California San Diego. She edited two books:  Motivational Interviewing for Clinical Practice and Absolute Addiction Psychiatry Review:  An essential board exam study guide. She has been highly involved in education of colleagues and trainees, and she is the fellowship director for the UCSD Addiction Psychiatry Fellowship. Dr. Marienfeld completed a fellowship in addiction psychiatry and residency training in psychiatry at Yale, and her medical degree with honors is from Baylor College of Medicine in Houston.

Rajesh Seenivasan, Ph.D.

RESEARCH SCIENTIST

Dr. Seenivasan received his Ph.D. in Chemistry from MaduraiKamaraj University, Tamil Nadu, India. As a Postdoc at the University of Wisconsin – Madison as well as UC San Diego, Dr. Seenivasan performed the multidisciplinary innovative research in the (bio)electroanalytical and surface chemistry field focusing on scalable point-of-care sensor/biosensor development.

Drew A. Hall, Ph.D.

TECHNICAL ADVISOR

Dr. Hall is an Associate Professor in the Electrical and Computer Engineering Department with an affiliate appointment in the Bioengineering Department at UCSD. He received his B.S. degree in computer engineering with honors from the University of Nevada, Las Vegas along with M.S. and Ph.D. degrees in electrical engineering from Stanford University. He has extensive technical experience in analog circuit design, CMOS integrated circuit design, sensor interfaces, biosensors, electrochemistry, and magnetic sensors. Dr. Hall was the recipient of the 2011 Analog Devices Outstanding Designer Award, won 1st place in both the inaugural international IEEE Change the World Competition and the BME-IDEA invention competition.

Laurie Russell

DIRECTOR, BUSINESS OPERATIONS

Laurie is an innovative executive with expertise implementing leading edge strategies to streamline business operations and increase profitability. She has experience in both the corporate and non-profit sectors not only in project management but also marketing, and business development.  She oversees the daily operations at CARI.

Contact Us

For direct inquiries, please contact laurie@caritherapeutics.com